Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
11%
Ph not_applicable
5
56%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Not yet recruiting2
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (16.7%)
N/A5 (83.3%)

Trials by Status

not_yet_recruiting222%
recruiting222%
completed444%
withdrawn111%

Recent Activity

Clinical Trials (9)

Showing 9 of 9 trials

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9